MRx roundup: J&J’s Janssen ‘Save Legs’ cam­paign de­tails first-year re­sults; AZ and Lil­ly both roll new tech tools

J&J’s Janssen is mak­ing progress with its pe­riph­er­al artery dis­ease cam­paign, “Save Legs. Change Lives,” aimed at reach­ing Black Amer­i­cans. Launched a year ago, the three-pronged re­search, part­ner­ship and com­mu­ni­ty ef­fort is rais­ing aware­ness and pro­mot­ing screen­ings to try to de­crease PAD-re­lat­ed am­pu­ta­tions.

For in­stance, Janssen’s em­pow­er­PAD mo­bile screen­ing RV-like ve­hi­cle is trav­el­ing the US and has al­ready pro­vid­ed more than 3,200 non-in­va­sive an­kle brachial in­dex (ABI) checks with some sur­pris­ing re­sults. Dur­ing one stop in Chica­go’s South Side neigh­bor­hood, Janssen part­nered with a faith-based lo­cal group to screen more than 650 peo­ple, with an “alarm­ing” 35% re­ceiv­ing a pos­i­tive test. That’s more than dou­ble the na­tion­al av­er­age of 14% — and val­i­da­tion for Janssen’s ef­fort.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.